1
|
Zhan GZ, Guo XY, Qiu ZC, Cai LY, Hu Q, Gao Y, Tang SW, Li CY, Zheng YF, Peng GP. Rapid evaluation of the quality of Smilax glabra Roxb. using QADS based on FT-NIR combined with multiple intelligent algorithms. Food Chem 2024; 453:139633. [PMID: 38781896 DOI: 10.1016/j.foodchem.2024.139633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2024] [Revised: 04/15/2024] [Accepted: 05/09/2024] [Indexed: 05/25/2024]
Abstract
Smilax glabra Roxb. (SGR) is known for its high nutritional and therapeutic value. However, the frequent appearance of counterfeit products causes confusion and inconsistent quality among SGR varieties. Herein, this study collected the proportion of SGR adulteration and used high-performance liquid chromatography (HPLC) to measure the astilbin content of SGR. Then Fourier-transform near-infrared (FT-NIR) technology, combined with multivariate intelligent algorithms, was used to establish partial least squares regression quantitative models for detecting SGR adulteration and measuring astilbin content, respectively. The method conducted a quantitative analysis of dual indicators through single-spectrum data acquisition (QADS) to comprehensively evaluate the authenticity and superiority of SGR. The coefficients of determination (R2) for both the calibration and prediction sets exceeded 0.96, which successfully leverages FT-NIR combined with multivariate intelligent algorithms to considerably enhance the accuracy and reliability of quantitative models. Overall, this research holds substantial value in the comprehensive quality evaluation in functional health foods.
Collapse
Affiliation(s)
- Geng-Zhi Zhan
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China
| | - Xin-Yue Guo
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China
| | - Zi-Chao Qiu
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China
| | - Lu-Yao Cai
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China
| | - Qian Hu
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China
| | - Ye Gao
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China
| | - Shu-Wan Tang
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China
| | - Cun-Yu Li
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China; National Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing 211100, China; Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China
| | - Yun-Feng Zheng
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China; National Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing 211100, China; Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| | - Guo-Ping Peng
- Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China; National Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing 211100, China; Jiangsu Province Engineering Research Center of Classical Prescription, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| |
Collapse
|
2
|
Zou H, Zhang Z, Zhang H, Chen Y, Zhang H, Yan J. Prediction of key quality attributes in Salvia miltiorrhiza standard decoction using a Gaussian process regression model. PHYTOCHEMICAL ANALYSIS : PCA 2024; 35:1345-1357. [PMID: 38686612 DOI: 10.1002/pca.3368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/05/2024] [Revised: 04/04/2024] [Accepted: 04/04/2024] [Indexed: 05/02/2024]
Abstract
INTRODUCTION Nonstationary, nonlinear mass transfer in traditional Chinese medicine (TCM) extraction poses challenges to correlating process characteristics with quality parameters, particularly in defining clear parameter ranges for the process. OBJECTIVES The aim of the study was to provide a solution for quality consistency analysis in TCM preparation processes. MATERIALS AND METHODS Salvia miltiorrhiza was taken as an example for 15 batches of standard decoction. Using aqueous extract, alcoholic extract, and the content of salvianolic acid B as herb material key quality attributes, multiple nonlinear regression, Gaussian process regression, and artificial neural network models were employed to predict the key quality attributes including the paste yield, the content of salvianolic acid B, and the transfer rate. The evaluation criteria were root mean square error, mean absolute percentage error, and R2. RESULTS The Gaussian process regression model had the best prediction effect on the paste yield, the content of salvianolic acid B, and the transfer rate, with R2 being 0.918, 0.934, and 0.919, respectively. Utilizing Gaussian process regression model confidence intervals, along with Shewhart control and intervals optimized through process capability index analysis, the quality control range of the standard decoction was determined as follows: paste yield, 25.14%-33.19%; salvianolic acid B content, 2.62%-4.78%; and transfer rate, 56.88%-64.80%. CONCLUSION This study combined the preparation process of standard decoction with the Gaussian process regression model, accurately predicted the key quality attributes, and determined the quality parameter range by using process analysis tools, providing a new idea for the quality consistency standard of TCM processes.
Collapse
Affiliation(s)
- Huosheng Zou
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China
| | - Zixia Zhang
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China
| | - Hongxu Zhang
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China
| | - Yuan Chen
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China
| | - Hui Zhang
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China
| | - Jizhong Yan
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China
| |
Collapse
|
3
|
Zeng Y, Zhao L, Hao M, Maimaiti M, Li Z, Zhang M, Ma X. Analysis of an Aqueous Extract from Turkish Galls Based on Multicomponent Qualitative and Quantitative Analysis Combined with Network Pharmacology and Chemometric Analysis. JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY 2024; 2024:9962574. [PMID: 38817340 PMCID: PMC11139529 DOI: 10.1155/2024/9962574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 03/22/2024] [Accepted: 05/03/2024] [Indexed: 06/01/2024]
Abstract
The current quality control method for Turkish gall (TG) is limited to assessing total tannin or gallic acid (GA), which offers a basic level of quality control but does not fully capture the true quality of TG. Therefore, it is essential to establish a comprehensive method that utilizes multiple indicators to assess the intrinsic quality of TG. This research utilized UPLC-Q-TOF-MS/MS technology to qualitatively analyze the chemical composition of TG. Subsequently, the potential main active ingredients, targets, and pathways of TG in treating recurrent aphthous ulcers (RAU) were explored and analyzed using network pharmacology technology. Quantitative analysis of multicomponents by single marker (QAMS) was then employed to quantify the primary pharmacodynamic components in TG. Finally, chemometrics analysis was utilized to interpret the measured results and identify the markers of scavenging quality. The study identified 36 chemical components in TG, highlighting ellagic acid (EA), GA, and so on as key components in treating RAU. A method for simultaneously determining GA, EA, 1,2,3,6-tetra-O-galloyl-β-D-glucose (TEGG) and 1,2,3,4,6-penta-O-galloyl-β-D-glucose (PEGG) in TG was established. Statistical analysis revealed significant differences in the content of these 4 components across 14 batches of TG, with GA and PEGG identified as the primary contributors to the variations. This study determined a quality index for TG, providing a reference for quality evaluation and introducing a cost-effective and efficient quality control method. Furthermore, it addressed the challenge of developing new Chinese medicine by overcoming the lack of reference substances.
Collapse
Affiliation(s)
- Ya Zeng
- Xinjiang Qimu Pharmaceutical Research Institute (Co., Ltd.), Urumqi 830011, Xinjiang, China
- College of Pharmacy, Xinjiang Medical University, Urumqi 830011, Xinjiang, China
| | - Lu Zhao
- Xinjiang Qimu Pharmaceutical Research Institute (Co., Ltd.), Urumqi 830011, Xinjiang, China
- College of Pharmacy, Xinjiang Medical University, Urumqi 830011, Xinjiang, China
| | - Meng Hao
- New Cicon Pharmaceutical Co., Ltd., Urumqi 830011, Xinjiang, China
| | - Mirzat Maimaiti
- New Cicon Pharmaceutical Co., Ltd., Urumqi 830011, Xinjiang, China
| | - Zhi Li
- Xinjiang Qimu Pharmaceutical Research Institute (Co., Ltd.), Urumqi 830011, Xinjiang, China
| | - Minghui Zhang
- Xinjiang Qimu Pharmaceutical Research Institute (Co., Ltd.), Urumqi 830011, Xinjiang, China
| | - Xuan Ma
- New Cicon Pharmaceutical Co., Ltd., Urumqi 830011, Xinjiang, China
- Xinjiang Key Laboratory of Generic Technology of Traditional Chinese Medicine (Ethnic Medicine) Pharmacy, Urumqi 830002, Xinjiang, China
| |
Collapse
|
4
|
Yang X, Qian H, Yang C, Zhang Z. Investigation of the molecular mechanism of Smilax glabra Roxb. in treating hypertension based on proteomics and bioinformatics. Front Pharmacol 2024; 15:1360829. [PMID: 38783958 PMCID: PMC11112092 DOI: 10.3389/fphar.2024.1360829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2023] [Accepted: 03/29/2024] [Indexed: 05/25/2024] Open
Abstract
Background Smilax glabra Roxb. (named tufuling in Chinese, SGR) has both medicinal and edible value. SGR has obvious pharmacological activity, especially in anti-inflammation and treating immune system diseases. This study investigated differential protein expression and its relationship with immune infiltration in hypertension treated with SGR using proteomics and bioinformatics. Methods N-Nitro L-arginine methyl ester (L-NAME) was used to replicate the hypertension model, with SGR administered by gavage for 4 weeks, and the systolic and diastolic blood pressure in each group of rats was measured using the tail-cuff method every 7 days. Furthermore, enzyme-linked immunosorbent assay (ELISA) was used to determine the serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) expressions in each group, followed by the detection of protein expression in rat liver samples using the tandem mass tag (TMT) technique. Additionally, hub targets were output using Cytoscape 3.9.1 software, and ALDH2 expression in the liver and serum in each group of rats was detected by ELISA. Moreover, R4.3.0 software was used to evaluate the relationship between acetaldehyde dehydrogenase 2 (ALDH2) and immune cells, and ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was performed to identify the components of SGR. Furthermore, the association between components of SGR and ALDH2 was analyzed with molecular docking and LigPlot1.4.5 software. Results Compared with the model group (L-NAME), SGR at high and medium doses reduced systolic and diastolic blood pressure while reducing TC, TG, and LDL-C levels and increasing HDL-C levels in hypertensive rats (p < 0.05). Moreover, 92 differentially expressed proteins (DEPs) were identified using TMT. These DEPs participated in peroxisome functioning, fatty acid degradation, and other signaling pathways, with ALDH2 being the core target and correlated with various immune cells. In addition, 18 components were determined in SGR, with 8 compounds binding to ALDH2. Molecular docking was performed to confirm that SGR played a role in hypertension based on the combined action of multiple components. Conclusion In conclusion, SGR has an antihypertensive effect on L-NAME-induced hypertension, with ALDH2 as its hub target. SGR may regulate neutrophil, regulatory T cell, and other cells' infiltration by targeting ALDH2, thereby contributing to the treatment of hypertension.
Collapse
Affiliation(s)
| | - Haibing Qian
- Guizhou University of Traditional Chinese Medicine, Guiyang, China
| | | | | |
Collapse
|
5
|
Li Y, Zhao Y, Niu X, Zhu Q, Wang X, Li S, Sun J, Hua S, Yang L, Yao W. Distinguishment of different varieties of rhubarb based on UPLC fingerprints and chemometrics. J Pharm Biomed Anal 2024; 241:116003. [PMID: 38301576 DOI: 10.1016/j.jpba.2024.116003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Revised: 01/22/2024] [Accepted: 01/25/2024] [Indexed: 02/03/2024]
Abstract
Rhubarb, a widely used traditional Chinese medicine (TCM), is primarily used for purging in practice. It is derived from the dried roots and rhizomes of R. tanguticum Maxim. ex Balf. (RT), Rheum officinale Baill. (RO) and R. palmatum L. (RP). To date, although the three varieties of rhubarb have been used as the same medicine in clinical, studies have found that they have different chemical compositions and pharmacological effects. To ensure the stability of rhubarb for clinical use, a simple and effective method should be built to compare and discriminate three varieties of rhubarb. Here, ultra-performance liquid chromatography-diode array detection (UPLC-DAD) fingerprints combined with chemometric methods were developed to evaluate and discriminate 29 batches of rhubarb. Similarity evaluation, hierarchical cluster analysis (HCA) and principal component analysis (PCA) showed that the chemical constituents of the three varieties of rhubarb were significantly different, and the three varieties could be effectively distinguished. Finally, all the 14 common peaks were identified by ultra-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry (UPLC-Q-TOF-MS). In this research, the developed UPLC fingerprints offer a simple, reliable and specific approach for distinguishing different varieties of rhubarb. This research aims to promote the scientific and appropriate clinical application of rhubarb from three varieties.
Collapse
Affiliation(s)
- Yuan Li
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
| | - Yan Zhao
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
| | - Xuan Niu
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
| | - Qianqian Zhu
- Jiangyin Tianjiang Pharmaceutical Co., Ltd., Wuxi 214400, China
| | - Xiehe Wang
- Jiangyin Tianjiang Pharmaceutical Co., Ltd., Wuxi 214400, China
| | - Song Li
- Jiangyin Tianjiang Pharmaceutical Co., Ltd., Wuxi 214400, China
| | - Jun Sun
- Jiangsu Food and Drug Administration Certification Review Center, Nanjing 210002, China
| | - Su Hua
- Jiangsu Food and Drug Administration Certification Review Center, Nanjing 210002, China
| | - Liwei Yang
- Jiangsu Food and Drug Administration Certification Review Center, Nanjing 210002, China.
| | - Weifeng Yao
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
| |
Collapse
|
6
|
Wu H, Lv Y, Tang R, Zhao M, Li Y, Wei F, Li C, Ge W, Du W. Analysis of Quality Differences in Radix Dipsaci before and after Processing with Salt Based on Quantitative Control of HPLC Multi-Indicator Components Combined with Chemometrics. Int J Anal Chem 2024; 2024:2109127. [PMID: 38357676 PMCID: PMC10866631 DOI: 10.1155/2024/2109127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2022] [Revised: 02/07/2023] [Accepted: 01/27/2024] [Indexed: 02/16/2024] Open
Abstract
Radix Dipsaci (RD) is the dry root of the Dipsacus asper Wall. ex DC., which is commonly used for tonifying the kidney and strengthening bone. The purpose of this study was to analyze the difference between raw and salt-processed RD from the chemical composition comprehensively. The fingerprints of raw and salt-processed RD were established by HPLC-DAD to determine the contents of loganin (LN), asperosaponin VI (AVI), caffeic acid (CaA), dipsanoside A (DA), dipsanoside B (DB), chlorogenic acid (CA), loganic acid (LA), isochlorogenic acid A (IA), isochlorogenic acid B (IB), and isochlorogenic acid C (IC). The results showed that after processing with salt, the components with increased contents were LA, CaA, DA, and AVI, and the components with decreased contents were CA, LN, IB, IA, IC, and DB. Then, the chemometric methods such as principal component analysis (PCA) and fisher discriminant analysis (FDA) were used to evaluate the quality of raw and salt-processed RD. In the classification of raw and salt-processed RD, the order of importance of each chemical component was LA > DB > IA > IC > IB > LN > CA > DA > AVI > CaA. These integrated methods successfully assessed the quality of raw and salt-processed RD, which will provide guidance for the development of RD as a clinical medication.
Collapse
Affiliation(s)
- Hangsha Wu
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China
| | - Yue Lv
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China
| | - Rui Tang
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China
| | - Mingfang Zhao
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China
| | - Yafei Li
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China
| | - Feiyang Wei
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China
| | - Changyu Li
- Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China
| | - Weihong Ge
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China
- Research Center of Traditional Chinese Medicine Processing Technology, Zhejiang Chinese Medical University, Hangzhou 311401, China
- Zhejiang Chinese Medical University Chinese Medicine Yinpian Co., Ltd, Hangzhou 311401, China
| | - Weifeng Du
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China
- Research Center of Traditional Chinese Medicine Processing Technology, Zhejiang Chinese Medical University, Hangzhou 311401, China
- Zhejiang Chinese Medical University Chinese Medicine Yinpian Co., Ltd, Hangzhou 311401, China
| |
Collapse
|
7
|
Guo Z, Ye G, Tang C, Xiong H. Exploring effect of herbal monomers in treating gouty arthritis based on nuclear factor-kappa B signaling: A review. Medicine (Baltimore) 2024; 103:e37089. [PMID: 38306549 PMCID: PMC10843426 DOI: 10.1097/md.0000000000037089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Accepted: 01/05/2024] [Indexed: 02/04/2024] Open
Abstract
Gouty arthritis (GA) is an inflammatory disease caused by disorders of the purine metabolism. Although increasing number of drugs have been used to treat GA with the deepening of relevant research, GA still cannot be cured by simple drug therapy. The nuclear factor-kappa B (NF-κB) signaling pathway plays a key role in the pathogenesis of GA. A considerable number of Chinese herbal medicines have emerged as new drugs for the treatment of GA. This article collected relevant research on traditional Chinese medicine monomers in the treatment of GA using NF-κB, GA, etc. as keywords; and conducted a systematic search of relevant published articles using the PubMed database. In this study, we analyzed the therapeutic effects of traditional Chinese medicine monomers on GA in the existing literature through in vivo and in vitro experiments using animal and cell models. Based on this review, we believe that traditional Chinese medicine monomers that can treat GA through the NF-κB signaling pathway are potential new drug development targets. This study provides research ideas for the development and application of new drugs for GA.
Collapse
Affiliation(s)
- Zhanghao Guo
- Hunan University of Chinese Medicine, Changsha, People’s Republic of China
| | - Guisheng Ye
- Department of Ophthalmology, The First Hospital of Hunan University of Chinese Medicine, Changsha, People’s Republic of China
| | - Chengjian Tang
- Department of Ophthalmology, The First Hospital of Hunan University of Chinese Medicine, Changsha, People’s Republic of China
| | - Hui Xiong
- Hunan University of Chinese Medicine, Changsha, People’s Republic of China
| |
Collapse
|
8
|
Cui L, Ma C, Shi W, Yang C, Wu J, Wu Z, Lou Y, Fan G. A Systematic Study of Yiqi Qubai Standard Decoction for Treating Vitiligo Based on UPLC-Q-TOF/MS Combined with Chemometrics, Molecular Docking, and Cellular and Zebrafish Assays. Pharmaceuticals (Basel) 2023; 16:1716. [PMID: 38139842 PMCID: PMC10747336 DOI: 10.3390/ph16121716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2023] [Revised: 11/27/2023] [Accepted: 12/07/2023] [Indexed: 12/24/2023] Open
Abstract
The Yiqi Qubai (YQ) formula is a hospital preparation for treating vitiligo in China that has had reliable efficacy for decades. The formula consists of four herbs; however, the extraction process to produce the formula is obsolete and the active ingredients and mechanisms remain unknown. Therefore, in this paper, fingerprints were combined with the chemometrics method to screen high-quality herbs for the preparation of the YQ standard decoction (YQD). Then, the YQD preparation procedure was optimized using response surface methodology. A total of 44 chemical constituents, as well as 36 absorption components (in rat plasma) of YQD, were identified via UPLC-Q-TOF/MS. Based on the ingredients, the quality control system of YQD was optimized by establishing the SPE-UPLC-Q-TOF/MS identification method and the HPLC quantification method. Network pharmacological analysis and molecular docking showed that carasinaurone, calycosin-7-O-β-d-glucoside, methylnissolin-3-O-glucoside, genkwanin, akebia saponin D, formononetin, akebia saponin B, and apigenin may be the key active components for treating vitiligo; the core targets associated with them were AKT1, MAPK1, and mTOR, whereas the related pathways were the PI3K-Akt, MAPK, and FoxO signaling pathways. Cellular assays showed that YQD could promote melanogenesis and tyrosinase activity, as well as the transcription and expression of tyrosinase-associated proteins (i.e., TRP-1) in B16F10 cells. In addition, YQD also increased extracellular tyrosinase activity. Further efficacy validation showed that YQD significantly promotes melanin production in zebrafish. These may be the mechanisms by which YQD improves the symptoms of vitiligo. This is the first systematic study of the YQ formula that has optimized the standard decoction preparation method and investigated the active ingredients, quality control, efficacy, and mechanisms of YQD. The results of this study lay the foundations for the clinical application and further development of the YQ formula.
Collapse
Affiliation(s)
- Lijun Cui
- School of Medicine, Tongji University, Shanghai 200331, China;
- School of Pharmacy, Naval Medical University, Shanghai 200433, China
| | - Cui Ma
- Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, China (C.Y.); (J.W.); (Z.W.)
- School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China
| | - Wenqing Shi
- Department of Pharmacy, Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine, Shanghai 200434, China
| | - Chen Yang
- Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, China (C.Y.); (J.W.); (Z.W.)
- School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
| | - Jiangping Wu
- Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, China (C.Y.); (J.W.); (Z.W.)
| | - Zhenghua Wu
- Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, China (C.Y.); (J.W.); (Z.W.)
- School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China
| | - Yuefen Lou
- School of Medicine, Tongji University, Shanghai 200331, China;
- Department of Pharmacy, Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine, Shanghai 200434, China
| | - Guorong Fan
- School of Medicine, Tongji University, Shanghai 200331, China;
- Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, China (C.Y.); (J.W.); (Z.W.)
- School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China
| |
Collapse
|